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ABSTRACT  
The use of crude herbal decoctions in the traditional treatment of diseases is a common practice.  Pogostemon benghalensis and P. cablin are 
commonly used for treatment of diverse categories of diseases such as infectious and non-infectious disease. Native people use the crude 
decoctions as bactericidal, antimalarial, anti-leshimania, anti-diarrheal and insecticidal activities. Its safety profile is not yet elucidated and 
therefore, this study was to analyze the acute toxicity of essential oils (Eos) from P. benghalensis and P. cablin as medicinal. Methods include 
acute toxicity study using male and female Wistar albino rats with single oral dose and followed up to 14 days as per the guidelines of OECD. 
Visual observations were carried regularly during the experimental period while body weight was measured weekly. Organ weight, clinical 
chemistry and hematology data were collected on the 7th and 14th days. Results were presented as mean ± standard deviation. One-way analysis 
of variance (ANOVA) was carried. Oral administration of Eos from P. benghalensis and P. cablin revealed no treatment-related mortality in 
female rats up to the dose of 5000 mg/kg. In acute toxicity studies, no remarkable treatment related anomalies were observed compared to 
negative controls. Food consumption, body weight, organ weight, hematology did not showed sound variation between controls an d treatment 
groups. However, creatinine, triglycerides, and monocytes were lower in the treated groups in 7th day as compared to control groups. No 
significant variations between male and female groups in relative organ weight, hematology were noticed. In conclusion, the Eos from P. 
benghalensis and P. cablin showed LD50 > 3000 mg/kg in acute toxicity studies. 
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INTRODUCTION 
Globally, secondary metabolites from plants are employed as 
therapeutics in primary health care system. Most of the 
crude extracts used by the native communities are non-
validated scientifically. The plant extracts can be harmful at 
certain concentrations, but may be safe and curative in other 
doses. Therefore, there is a range of possible impacts from 
acute to sub-acute level of toxicity. The plants synthesize the 
pool of phytochemicals like protein, sugar, lipids, 
polyphenols, alkaloids, saponins, nitrogen conjugates etc. as 
a part of defense mechanisms against grazing animals or 
invading pathogens. Many synthetic compounds that have 
been proven as toxic even in minute quantities, while the 
plant-based drugs have been employed to prevent, diagnose, 
and treat diverse disorders. This therapy has been practiced 
out for the past several decades. Exposure of a 
phytochemical in human beings can be studied by analyzing 
the cumulative effects and concentrations that may be 
carcinogenic, mutagenic, teratogenic, skin or eye irritation 
and others1. Toxicity testing is essential to quantify the 
damage level caused by the molecules to biological and non-
biological compounds of the cell system. This acute oral 
toxicity test is usually attempted on prospective products to 
develop novel drugs and to determine their therapeutic 
potentials2. 
Lack of evidence-based approaches like the legal and 
regulatory framework, pharmacovigilance, non-
standardization and lack of toxicological profiling of herbal 
products form the greatest concern of medicinal plants 
usage3, 4. Plants synthesize diverse metabolites that form 
complex molecules that may be beneficial or harmful to 
humans5, 6. The general view is that natural plant based 
products are safe and without side effects and is proven false 
in some cases7. Investigations carried out on many plant 
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species revealed toxic substances. Despite the widespread 
crude usage of Pogostemon benghalensis and P. cablin in 
traditional medicine, there is a lack of experimental data on 
its possible toxicity. In addition, allelopathic enthusiasts 
criticize herbal specialties in terms of organ damage. To 
eliminate these issues and to ensure the safety of the herbals 
like P. benghalensis and P. cablin, the present study was 
carried in terms of acute toxicity analysis of essential oils 
extract via administered orally in male and female Wistar 
rats. 
MATERIALS AND METHODS 
Plant Material 
Fresh leaves and twigs of Pogostemon benghalensis and P. 
cablin used in the present study were collected from the 
natural habitats of Munnar Hills of Idukki district, Kerala, 
India on July 2019. The collected species were identified 
using flora and were authenticated at the Herbarium of 
Jawaharlal Nehru Tropical Botanic Garden and Research 
Institute (JNTBGRI), Palode, Trivandrum, Kerala, India. The 
voucher specimens were numbered (MGH 1456 and 1457 
for Pogostemon benghalensis and P. cablin respectively) and 
kept in the herbarium of the Department of Botany, 
Mahatma Gandhi College, Trivandrum, Kerala, India. The 
collected plants were washed thoroughly with running tap 
water and the hydro-distillation of fresh leaves were carried 
out using a Clevenger-type apparatus to extract the essential 
oil. 
Animals 
The healthy Wistar rats of 8 to 10 weeks aged with the body 
weight of 120–140 g were used for the present acute oral 
toxicity studies. The rats were caged in standard lab 
conditions for 5 days at the temperature of 23°C (± 1°C), 
with 12 h light/ dark cycle. They were given standard diet 
and water ad libitum8, 9. 
Rats were randomly categorized in to control and 
experimental groups. A total of 30 rats containing 6 rats per 
group (three male and three female, I to V group) were used 
for acute toxicity study a control (water alone), tween-20 
(solvent) and six treatment classes (of Eos from P. 
benghalensis and P. cablin solubilized i.e., 500, 1500 and 
3000 mg/kg b.w). All classes of the rats were fasted 
overnight prior to Eos administrations. After the fasting 
period, all rats were weighed, and the concentrations were 
carried based on their body weight. The extracts were 
prepared in tween-20. Eos of the two species were 
separately mixed in tween-20 at the ratio of 1: 1 v/v in glass 
tubes and labelled carefully. Rats in groups III to V were 
given single oral dose of the respective oil by using feeding 
needle and rats were kept without food for 3–4 h prior to 
administration. Initially, the rats were closely observed for 
first 60 min, intermittently for 4 h and thereafter once every 
24 h for 14 days. Food was given after 1–2 h of dosing. The 
same procedure was carried for the vehicle group of 6 rats to 
whom tween-20 was administered in same volume as that of 
treated groups. Both the groups were observed closely for 
any toxic effect at regular intervals for a total period of 
14 days. Surviving rats were observed to determine the toxic 
reactions onset. Weights of animals were monitored and 
documented as well. At the end of study, rats were weighed 
and blood samples were collected by cardiac puncture under 
anesthesia with isoflurane and serum was separated for 
biochemical and hematological evaluations. Vital organs 
were excised after killing mice by cervical dislocation and 
the weight of organs was noted. 
Biochemical assay 
The biochemical parameters include serum urea, serum 
creatinine, alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), alkaline phosphate (AP),total 
bilirubin, total protein, albumin, globulins, cholesterol, 
triglycerides (TGA), high density lipoprotein (HDL), low 
density lipoprotein (LDL) and very low density lipoprotein 
(VLDL) were measured by using Randox kits. 
Hematological evaluations 
The blood samples from animals (both treated and vehicle 
control groups) were collected in EDTA containing tubes for 
hematological study. Hemoglobin (Hb), total red blood cells 
RBC, hematocrit (HCT), mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), platelet count, white 
blood cells count (WBC), neutrophils, lymphocytes, 
monocytes and eosinophils were determined with automatic 
hematology analyzer. 
Statistical analysis 
Experimental results were presented as mean ± SD and the 
statistical significance between the groups was analyzed by 
means of one way ANOVA followed by Tukey’s multiple 
comparison test. P ≤ 0.05 was considered as statistically 
significant. 
RESULTS AND DISCUSSION 
The doses of Eos from P. benghalensis and P. cablin employed 
were 500, 1500 and 3000 mg/kg body weight of rats in the 
test groups. Control class (I and II) received water and 
tween-20 respectively. After feeding the Eos, the rats were 
kept under close vision continuously for 1 h and 
intermittently for 4 h and thereafter once every 24 h for 14 
days. 
During this course of experimental periods, medical 
observations were carried for mortality, behavioral changes, 
neurological features and other anomalies. The body weight 
was measured weekly. Finally, the gross physical 
examinations were attempted. The animals were then 
anesthetized under isoflurane. After sacrificing, gross 
pathological features of the rats were attempted on the vital 
organs. 
The acute toxicity analyzes did not revealed any toxic 
symptoms or signs among the experimental groups of male 
and female rats from 500 to 3000 mg/kg b.w. No morbidity 
or mortality was noticed in the administrated rats at the 
above specified doses during the acute toxicity studies. As a 
result, the LD50 of the Eos from P. benghalensis and P. cablin 
should be higher than 3000 mg/kg body weight. 
The gross pathological analyzes of the kidneys and liver of 
Eos from P. benghalensis and P. cablin administrated rats 
revealed no anomalous physical changes in terms of size, 
shape, color, and texture as compared with the control 
groups. The absolute mean liver weights were 5.52 g (at 
1500 mg/kg P. benghalensis), 5.67g (at 3000 mg/kg P. 
benghalensis) compared with the control (5.43 g). Similarly, 
the absolute mean kidney weights were 1.18 g (at 1500 
mg/kg P. benghalensis) and 1.17 g (at 3000 mg/kg P. 
benghalensis) as compared with the control group (1.17 g) 
(Fig.1). Similarly, the liver weights were 5.59 g (at 1500 
mg/kg P. cablin) and 5.71g (at 3000 mg/kg P. cablin). 
Similarly, the absolute mean kidney weights were 1.21 g (at 
1500 mg/kg P. cablin) and 1.22 g (at 3000 mg/kg P. cablin) 
(Fig.1).  
Pardeep et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2020; 10(3):142-147 
ISSN: 2250-1177                                                                                  [144]                                                                                 CODEN (USA): JDDTAO 
There was a gradual increase in the body weight of both the 
treated and control rats (Table 1). The initial mean body of 
control rats was 123.67g; at the end of the experiment their 
final mean body weight was 136.21 g. The mean body weight 
gain for the control rats was 12.54 g. The initial mean body 
weights of rats treated with doses of 1500 mg/kg, and 3000 
mg/kg of Eos from P. benghalensis were 126.2 g, and 127.8g 
respectively. At the end of the experiment (after 14 days) the 
final mean body weight of rats treated with 1500 mg/kg and 
3000 mg/kg was 139.1 g and 140.4 g, respectively. The mean 
body weight gain for rats treated with 1500 mg/kg, and 
3000 mg/kg of P. cablin was 140.2 g and 141.1 g respectively 
(after 14 days) (Table 1). 
 
 
Figure 1: Liver and kidney weights of rats treated with Eos from P. benghalensis and P. cablin 
 
Table 1: Body weights of rats treated with Eos from P. benghalensis and P. cablin 
Treatment groups P. benghalensis P. cablin 
 1 weak 2 weak 1 weak 2 weak 
Control 123.67 ±0.56 136.21 ±0.18 123.67 ±0.23 136.21±0.44 
Tween-20 127.45 ±0.71 134.5 ±0.87 127.45±0.25 134.5±0.03 
500 mg/kg 125.1 ±0.27 134.4 ±0.34 126.3±0.23 133.9±0.99 
1500 mg/kg 126.2 ±0.67 139.1 ±0.24 127.0 ±0.18 140.2±0.21 
3000 mg/kg 127.8 ±0.38 140.4 ±0.31 127.93±0.26 141.1±0.36 
 
 
Acute toxicity analysis is a pre-requisite to evaluate the 
adverse impacts that happen within a short time of 
administration of a herbal drug. Principally, such tests are 
carried in rats/mice and are usually attempted in designing 
a new drug or crude product to gain amble knowledge on its 
toxicity potentials4. 
For acute toxicity study, 500, 1500 and 3000 mg/kg of Eos 
from P. benghalensis and P. cablin were given to rats. The 
rats did not show any signs/symptoms of toxicity at all the 
tested concentrations. No mortality was seen in the 
administrated rats, i.e., even at 3000 mg/kg during the 
course of the study period. Thus, the LD50 of the Eos could be 
higher than 3000 mg/kg. The Eos from P. benghalensis and P. 
cablin was considered safe on acute dose exposure. 
Biochemical parameters 
No sound serum creatinine level change was noticed; 
meanwhile serum urea level in acute toxicity group was 
slightly higher as compared to vehicle control group (Table 
2). Biochemical markers of liver function test revealed 
significant (p <0.05) changes (Table 2).There was no 
remarkable variation in the creatinine and urea level in the 
control and treated groups. Alanine aminotransferase (ALT), 
aspartate aminotransferase (AST) levels were increased. 
Meanwhile, alkaline phosphatase (AP) was reduced in acute 
toxicity group as compared to vehicle control group. 
 
 
 
 
Pardeep et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2020; 10(3):142-147 
ISSN: 2250-1177                                                                                  [145]                                                                                 CODEN (USA): JDDTAO 
Table 2: Biochemical parameters of rats treated with Eos from P. benghalensis and P. cablin 
Parameters Vehicle control 
group 
Acute toxicity group (Eos from P. 
benghalensis  - 3000 mg/kg b.w) 
Acute toxicity group (Eos from 
P. cablin - 3000 mg/kg b.w) 
Creatinine serum (mg/dl) 0.396 ±0.065 0.392 ±0.01 0.402 ±0.05 
serum urea (mg/dl) 17.86 ±0.14 18.05 ±0.28 18.84 ±0.43 
ALT (U/L) 210.0 ±2.55 248.7 ±1.54 251.0 ±2.65 
AST (U/L) 336.6 ±1.89 339.0 ±2.38 340.6 ±2.55 
AP (U/L) 165.2 ±0.56 124.3 ±0.09 128.4 ±0.54 
 (ALT- Alanine aminotransferase, AST- Aspartate aminotransferase, AP- Alkaline phosphatase) 
 
Total protein and globulin levels were increased. However, 
no remarkable changes were seen in total bilirubin and 
albumin among the tested groups.  It was also noticed that 
when the Eos treated groups was compared with vehicle 
control group in terms of HDL and VLDL showed no sound 
variations, however there was significant (p <0.05) increase 
in cholesterol, triglycerides (TGA) and LDL (Table 3). 
 
Table 3: Biochemical parameters of rats treated with Eos from P. benghalensis and P. cablin 
Parameters Vehicle control group Acute toxicity group (Eos from P. 
benghalensis  - 3000 mg/kg b.w)  
Acute toxicity group (Eos from 
P. cablin - 3000 mg/kg b.w)  
Total bilirubin (mg/dl) 0.91 ±0.07 0.915±0.006 0.920±0.013 
Total protein (U/dl) 6.7 ±0.21 7.59±0.09 7.96±0.25 
Albumin (U/dl) 4.62±0.054 4.59 ±0.21 4.69±0.05 
Globulin (U/dl) 2.4±0.38 2.64 ±0.12 2.72 ±0.021 
Cholesterol (mg/dl) 164.36±0.89 173 ±0.02 174.89 ±0.12 
TGA (mg/dl) 126.2 ±0.18 148 ±0.31 150 ±0.27 
HDL (mg/dl) 31 ±0.21 35 ±0.29 36.2 ±0.33 
LDL (mg/dl) 111 ±0.056 129.56 ±0.18 131±0.65 
VLDL (mg/dl) 24.5±0.34 28.9 ±0.21 29.2 ±0.28 
 (TGA- Triglycerides, HDL- High density lipoprotein, LDL- Low density lipoprotein, VLDL-Very low density lipoprotein) 
 
In acute toxicity evaluation of Eos from P. benghalensis and 
P. cablin, the health status of the animal was evaluated by 
biochemical parameters including serum biomarkers 
activity levels. Ramaiah10 and Ozer11 reported that liver 
damages due to hepatotoxic chemicals can elevate the ALT, 
AST and total proteins levels. Remarkable elevation in ALT, 
AST, total proteins and globulin levels were seen in the 
present study (Table. 2). Adedapo12 reported the toxic 
effects of Euphorbia species on hematological and 
biochemical parameters of rats.  Similarly, Adeoye13 
correlated the genotoxic and systemic toxicity of 
pharmaceutical effluent in Wistar rats with oxidative stress. 
Ogunlana14 evaluated the toxicological profile of the 
Caesalpinia bonduc extract. Ali15 documented cytogenetic 
damage among the female agricultural workers of Pakistan 
exposed to pesticides. Hepato cellular damage may leads to 
increased cell membrane permeability and release of amino 
transferases into the blood stream. AP is treated as the 
indicator of biliary tract obstruction16.  In the present study, 
there was remarkable reduction in AP levels was noticed 
(Table. 2) which is a sign of herbal hepato protective effect. 
Multiple hyperlipidemias are often secondary to many 
factors like over diet, alcohol intake, therapies or to diseases 
like nephrosis, diabetes, hypothyroidism or tumors17. 
Enhanced cholesterol, triglycerides and LDL levels noticed in 
the experimental group suggests the multiple 
hyperlipidemic impacts of Eos of Pogostemon species. 
Goldstein18 reported the hyperlipidemia in coronary heart 
disease in 176 families and delineation of a new inherited 
disorder. Travlos19 reported that renal function impairment 
is reflected by increased levels of serum creatinine and urea. 
In the present data, serum urea levels were found elevated 
(Table 2) revealing that there is a marginal renal injury. 
Hematological data 
Blood parameters are sensitive indicators of the 
physiological changes in response to any pollutant or stress 
in animals20. Blood platelets have key role in blood clotting 
processes. This study revealed significant increase in  
platelet count levels as compared to control vehicle group 
(Table 4) reflecting hemostatic potential of tested Eos. Li21 
reported similar stand on the hemostatic activity of the 
Tibetan herb Lamiophlomis rotate. In the present study 
increased level of mean corpuscular volume (MCV) and 
reduced mean corpuscular hemoglobin concentration 
(MCHC) was noticed (Table 4). Elevated WBC count and 
lymphocytes refers the potentiality of Eos defending nature 
against the pathogens and also its contribution to enhance 
cellular inflammatory events. The hematological data of 
vehicle group and Eos treated group are illustrated in Table 
4.
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Table 4: Hematological parameters of rats treated with Eos from P. benghalensis and P. cablin 
Parameters Vehicle control 
group 
Acute toxicity group (Eos from P. 
benghalensis  - 3000 mg/kg b.w) 
Acute toxicity group (Eos from 
P. cablin - 3000 mg/kg b.w) 
Hb (g/dl) 12.1±0.21 12.78 ±0.23 12.9 ±0.31 
Total RBC (1012/l) 7.42 ± 0.04 7.89 ±0.08 7.92 ±0.06 
HCT (%) 33.5 ±0.11 41.69 ±1.32 42.3 ±1.28 
MCV  (fl) 45.4 ±0.25 54.3 ±0.78 55 ±0.99 
MCH (pg) 16.02 ±0.45 16.09 ±0.21 16.08 ±0.33 
MCHC (g/dl) 35.3 ± 0.254 27.8 ±0.28 29 ±0.93 
Platelet count (x109/l) 246 ±1.43 490 ±2.34 493 ±3.01 
WBC Count (109/l) 3.3 ±0.09 5.23 ±0.76 5.4 ±0.54 
Neutrophil (%) 9.9 ±0.03 10.3 ±0.73 10.5 ±0.27 
Lymphocytes % 85 ±0.76 87 ±0.58 89 ±0.87 
Monocytes % 2.9 ±0.1 3.9 ±0.03 4.09 ±0.04 
Eosinophils % 1.02 ±0.04 2.03 ±0.21 2.06 ±0.06 
 (Hb-Hemoglobin, RBC-Red blood cells, HCT-Hematocrit, MCV-Mean corpuscular volume, MCH-Mean corpuscular hemoglobin, 
MCHC-Mean corpuscular hemoglobin concentration, WBC-White blood cells) 
 
The present results from the acute toxicity study of Eos from 
P. benghalensis and P. cablin supports the nontoxic nature of 
herbal extracts and was comparable with the reports by 
other researchers10, 11, 12. Further, the results of Eos extracts 
showed no symptom of toxicity or mortality even at 3000 
mg/kg concentration of the species. Ior22 showed that the 
LD50 of ethanolic extract from the leaves of Syzygium 
guineense was 4000 mg/kg.  
Variations in body weight are a marker character for 
evaluating the toxicity of plant drugs. In the present work, 
there was no remarkable increase in the absolute mean body 
weight of the treated rats as compared to control groups. The 
absolute mean body weight for the Eos treated rats was 
140.4 and 141.1 g as compared to control 136.2 g (after 14 
days). The mean body weight gain for rats treated with 1500 
mg/kg and 3000 mg/kg were statistically insignificant. 
Liver and kidneys of animals are employed by many 
researchers to analyze the safety or toxicity of drugs or 
phytochemicals. In the present acute toxicity study, gross 
pathological results of the kidneys and liver of treated rats 
did not showed much visual variation in terms of size, shape, 
color, and texture when compared with control groups. 
Further, there were no remarkable variations in the absolute 
weight of liver and kidneys of Eos administrated animals as 
compared to control groups. Vahalia23 analyzed the chronic 
toxicity versus generic ayurvedic mineral formulation tamra 
bhasma in laboratory animals and substantiated its safety as 
drugs. Abba24 analyzed the hemorrhagic centrolobar 
necrosis and cytoplasmic vacuolation of the hepatocytes in 
Syzygium guineense treated mice.   Loha25 authenticated 
methanolic leaf extract of Syzygium guineense in terms of 
histology of the liver, kidney and biochemical compositions 
of blood in rats used in acute and sub acute toxicity studies.  
Chlorophytum alismifolium tuber extract’s non toxic nature 
was established by acute and sub-acute toxicity studies in 
Wistar rats by Abubakar26. Chebaibi27reviewed the acute 
toxicity of plant mixture employed in traditional treatment of 
kidney diseases in Morocco. Jatsa28 evaluated the acute and 
sub-chronic oral toxicity studies of the aqueous leaf extract 
of Clerodendrum umbellatum on mice. Hemalatha29 
confirmed the safety of Trema orientalis methanol extract in 
rats by acute and sub-acute toxicity studies.  Gebrehiwot30 
proved the non-toxic potential of root extract of Carissa 
spinarum by in vivo acute and sub-acute toxicity studies in 
Swiss albino mice.  Abotsi31 compared the acute and sub-
acute toxicity of the ethanolic extract of the aerial parts of 
Hilleria latifolia in rodents. Jothy32 documented the acute 
oral toxicity of methanolic seed extract of Cassia fistula in 
mice. Kpemissi33 proved the acute and sub chronic oral 
toxicity assessments of Combretum micranthum in Wistar 
rats. Pal and Mishra34 evaluated acute toxicity of the 
methanolic extract of Dhatryadi ghrita in Wistar rats. Acute 
and sub-acute toxicity of Echinops kebericho decoction in rats 
was validated by Deyno35. Gaelle36 documented acute and 
sub acute toxicity profiles of the methanol extract of 
Lycopersicon esculentum. All the above plant based works 
justify the present data on rats treated with Eos from P. 
benghalensis and P. cablin. 
CONCLUSION 
 In the background of findings of acute toxicity studies it was 
possible to suggest that Eos from P. benghalensis and P. 
cablin is safe and non toxic based on the mortality, 
behavioural evaluation, mass of organs, biochemical and 
hematological parameters.  However, the results should be 
further evaluated for long term usage and repeated dose 
effects to ensure safety of these aromatic species. 
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